Biden-Harris FTC Accuses Major Healthcare Companies Of Artificially Inflating Drug Prices In New Lawsuit
1 sourceUpdated Jul 1, 2026
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and their affiliates, alleging the companies schemed to artificially inflate insulin drug prices…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup

